Choate Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $244K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $356K | Buy |
|
|||||
|
2024
Q4 | $392K | Buy |
|
|||||
|
2024
Q3 | $540K | Buy |
|
|||||
|
2024
Q2 | $518K | Sell |
|
|||||
|
2024
Q1 | $476K | Sell |
|
|||||
|
2023
Q4 | $487K | Sell |
|
|||||
|
2023
Q3 | $519K | Buy |
|
|||||
|
2023
Q2 | $375K | Buy |
|
|||||
|
2023
Q1 | $324K | Hold |
|
|||||
|
2022
Q4 | $284K | Hold |
|
|||||
|
2022
Q3 | $271K | Hold |
|
|||||
|
2022
Q2 | $233K | Hold |
|
|||||
|
2022
Q1 | $275K | Hold |
|
|||||
|
2021
Q4 | $249K | Hold |
|
|||||
|
2021
Q3 | $238K | Hold |
|
|||||
|
2021
Q2 | $220K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $228K | Buy |
|